Skip to main content
Caplight Logo









Stämm

Stämm

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.stamm.bio/

Last Round

Series A

Mar 1, 2022

Total Funding Raised

$19.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Stämm is a biotechnology company that develops advanced biomanufacturing solutions, specializing in automated, continuous production processes for biologics, cell therapies, and emerging applications using microfluidics and 3D printing technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

microfluidicsbioprocessingbioreactorcontinuous biomanufacturingbiomanufacturingcell culturelab-on-a-chipbiotech equipmentlab automationbiotech scale-upbioprocess optimizationcell therapy manufacturingbiotech hardwarebio-aismart manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stämm Comparables

Compare Stämm with similar companies based on industry and business-model similarity.

Stämm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Astraveus
82%
Ori Biotech
81%
MFX
80%

Stämm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 1, 2022
SeedJun 27, 2019
AcceleratorSep 20, 2018
AcceleratorJul 25, 2018

Key People

Founding team and executive leadership

Yuyo Llamazares Vegh

CEO Founder

Founding Team

Juan Martin Cabaleiro

Chief Technology Officer

Executive Team

Federico D'Alvia Vegh

Fundador Y COO

Executive Team

Stämm Investors

Notable investors and investment history

Stämm investors
InvestorRounds
VX VenturesSeries A
GRIDXSeries A
Varana CapitalSeries A
Teramips TechnologiesSeries A
IndieBioAccelerator
Draper AssociatesSeries A, Seed
Draper CygnusSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 445% MoM, reaching 4.3K.

  • Mar 12, 2026

    Launched the High-Throughput Bioprocessor (HTB) for biomanufacturing.

Stämm Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stämm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stämm's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range147
Year Founded2014
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?